For: | Chapman JAW, Pritchard KI, Goss PE, Ingle JN, Muss HB, Dent SF, Vandenberg TA, Findlay B, Gelmon KA, Wilson CF, Shepherd LE, Pollak MN. Competing risks of death in younger and older postmenopausal breast cancer patients. World J Clin Oncol 2014; 5(5): 1088-1096 [PMID: 25493245 DOI: 10.5306/wjco.v5.i5.1088] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v5/i5/1088.htm |
Number | Citing Articles |
1 |
Doris S.M. Chan, Rita Vieira, Leila Abar, Dagfinn Aune, Katia Balducci, Margarita Cariolou, Darren C. Greenwood, Georgios Markozannes, Neesha Nanu, Nerea Becerra‐Tomás, Edward L. Giovannucci, Marc J. Gunter, Alan A. Jackson, Ellen Kampman, Vivien Lund, Kate Allen, Nigel T. Brockton, Helen Croker, Daphne Katsikioti, Deirdre McGinley‐Gieser, Panagiota Mitrou, Martin Wiseman, Amanda J. Cross, Elio Riboli, Steven K. Clinton, Anne McTiernan, Teresa Norat, Konstantinos K. Tsilidis. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis. International Journal of Cancer 2023; 152(4): 572 doi: 10.1002/ijc.34322
|
2 |
Rachel S. Morris, Christopher J. Tignanelli, Terri deRoon-Cassini, Purushottam Laud, Rodney Sparapani. Improved Prediction of Older Adult Discharge After Trauma Using a Novel Machine Learning Paradigm. Journal of Surgical Research 2022; 270: 39 doi: 10.1016/j.jss.2021.08.021
|
3 |
M.G.M. Derks, E. Bastiaannet, W. van de Water, N.A. de Glas, C. Seynaeve, H. Putter, J.W.R. Nortier, D. Rea, A. Hasenburg, C. Markopoulos, L.Y. Dirix, J.E.A. Portielje, C.J.H. van de Velde, G.J. Liefers. Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial. European Journal of Cancer 2018; 99: 1 doi: 10.1016/j.ejca.2018.04.009
|
4 |
Judith-Anne W. Chapman, Lois E. Shepherd, James N. Ingle, Hyman B. Muss, Kathleen I. Pritchard, Karen A. Gelmon, Timothy J. Whelan, Catherine Elliott, Paul E. Goss. Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27. Breast Cancer Research and Treatment 2016; 156(2): 343 doi: 10.1007/s10549-016-3761-8
|
5 |
Acquah Joseph, Bosson-Amedenu Senyefia, Eyiah-Bediako Francis, Anafo Yen Abdulzeid. Covariate level stratification assessment of mortalities due to competing risks and breast cancer in Ghana. Scientific African 2024; 23: e02060 doi: 10.1016/j.sciaf.2024.e02060
|
6 |
V. Formica, C. Morelli, S. Riondino, N. Renzi, D. Nitti, N. Di Daniele, M. Roselli, M. Tesauro. Obesity and common pathways of cancer and cardiovascular disease. Endocrine and Metabolic Science 2020; 1(3-4): 100065 doi: 10.1016/j.endmts.2020.100065
|
7 |
Willeke G van der Plas-Krijgsman, Anna Z. de Boer, Pauline de Jong, Esther Bastiaannet, Frederiek van den Bos, Simon P. Mooijaart, Gerrit Jan Liefers, Johanneke E.A. Portielje, Nienke A. de Glas. Predicting disease-related and patient-reported outcomes in older patients with breast cancer - a systematic review. Journal of Geriatric Oncology 2021; 12(5): 696 doi: 10.1016/j.jgo.2021.01.008
|
8 |
Trygve Lofterød, Hanne Frydenberg, Vidar Flote, Anne Elise Eggen, Anne McTiernan, Elin S. Mortensen, Lars A. Akslen, Jon B. Reitan, Tom Wilsgaard, Inger Thune. Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study. Breast Cancer Research and Treatment 2020; 182(1): 215 doi: 10.1007/s10549-020-05679-2
|
9 |
Kirsten A. Nyrop, Emily M. Damone, Allison M. Deal, Lisa A. Carey, Michael Lorentsen, Shlomit S. Shachar, Grant W. Williams, Addison (Tucker) Brenizer, Amy Wheless, Hyman B. Muss. Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer. Cancer 2021; 127(6): 922 doi: 10.1002/cncr.33288
|
10 |
Panagiotis F. Christopoulos, Alexandre Corthay, Michael Koutsilieris. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics. Cancer Treatment Reviews 2018; 63: 79 doi: 10.1016/j.ctrv.2017.11.010
|
11 |
Judith-Anne W. Chapman, Joseph P. Costantino, Bin Dong, Richard G. Margolese, Kathleen I. Pritchard, Lois E. Shepherd, Karen A. Gelmon, Norman Wolmark, Michael N. Pollak. Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29. Breast Cancer Research and Treatment 2015; 153(2): 353 doi: 10.1007/s10549-015-3547-4
|
12 |
Judith-Anne W. Chapman, Shuzhen Liu, Samuel Leung, Torsten O. Nielsen. Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer. Clinical Breast Cancer 2017; 17(4): e215 doi: 10.1016/j.clbc.2017.01.002
|
13 |
Seung-Hyuk Shim, Myong Cheol Lim, Dahhay Lee, Young-Joo Won, Hyeong In Ha, Ha Kyun Chang, Hyunsoon Cho. Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study. Journal of Gynecologic Oncology 2022; 33(1) doi: 10.3802/jgo.2022.33.e5
|